by The Welsh Aspirin Group Peter Elwood, Gareth Morgan, Richard Adams, Christine Delon, Marcus Longley, Simon Noble, Janet Pickering, Majd Protty, John Watkins, Anna Yeatman Corresponding author: Gareth Morgan ABSTRACT: Aspirin is a remarkable drug that has been shown in more than fifty years of research to be beneficial at Read more
Myeloproliferative neoplasms (MPN’s) are a group of blood cancers. MPN’s are bone marrow disorders which results in an excess of blood cells. As a result, these blood cancers are associated with risks of clots and low-dose aspirin is often used in many patients along with other treatments. There are three Read more
Abstract There is a growing body of evidence that aspirin could be helpful in the treatment of cancer. In this paper, ten randomised controlled trials are reviewed covering more than 8,000 patients with several different forms of the disease. It appears that aspirin is well tolerated and the evidence of Read more
An abstract by Dr Gareth Morgan, John Watkins, Majad Protty and Professor Peter Elwood Click image for link to the article.
There are four basic ethical principles in clinical practice: non-maleficence; beneficence; autonomy and justice. Evidence upon which each of these is judged comes from appropriate research, but there are also personal opinions and claims – many of which are supported by little, if any, research evidence. The evaluation of evidence Read more
Aspirin and the Prevention of Cancer: The Emerging Evidence – Cardiff University School of Medicine.